NSPXD:Rebus Holdings Inc - Stock Price Quote and Dividend Data

NSPXD STOCK PRICE LATEST CLOSE

$0.10

EXCHANGE

OTCBB

NSPXD

Rebus Holdings Inc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
NSPXD

Rebus Holdings Inc Stock Price Information

NSPXD Stock Price Latest Close$0.10
52-Week Low/High Stock Price$0.08 - $4.28
Percent Held by Institutions0.00%
Revenue$0
Net Income$9,283,000
Cash Flow$-128,000
EPS2.25%
Market Cap$689,438
PE Ratio0
PE Ratio to Industry45%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry1.05%
Total Return Last 12 Months-90.16%
Total Return Last 3 Years-99.96%
Total Return Last 5 Years-100.00%
Latest Trade DateNov. 08, 2021
NSPXD

Rebus Holdings Inc Annual Stock Dividends

No Data available for Payment History.

NSPXD

Rebus Holdings Inc Dividend Payment History

No dividends retrieved for NSPXD
NSPXD

Rebus Holdings Inc Other Dividend Details

Inspyr Therapeutics is a clinical-stage, pre-revenue, pharmaceutical company primarily focused on the development of therapeutics for the treatment of diseases. Through its wholly owned subsidiary, Lewis & Clark Pharmaceuticals, Inc., Co. is focusing on a pipeline of small molecule adenosine receptor modulators. The adenosine receptor modulators include A2B antagonists, dual A2A/A2B antagonists, and A2A agonists that have development applicability including indications within immuno-oncology and inflammation. Adenosine is implicated in immunosuppression in the tumor microenvironment. Adenosine also has anti-inflammatory properties in the acute and chronic setting.

Web Sitewww.genspera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Rebus Holdings Inc Dividend Stock News and Updates

Nov. 05, 2021NSPXD STOCK PRICE DECREASE: Rebus Holdings Inc on 11-05-2021 decreased stock price > 10% from $0.11 to $0.10

Oct. 19, 2021NSPXD STOCK PRICE INCREASE: Rebus Holdings Inc on 10-19-2021 increased stock price > 10% from $0.11 to $0.13

Oct. 14, 2021NSPXD STOCK PRICE DECREASE: Rebus Holdings Inc on 10-14-2021 decreased stock price > 10% from $0.15 to $0.13

Oct. 13, 2021NSPXD STOCK PRICE INCREASE: Rebus Holdings Inc on 10-13-2021 increased stock price > 10% from $0.04 to $0.15

Jul. 25, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-25-2020 decreased close price > 10% from $0.05 to $0.04

Jul. 24, 2020CLOSE PRICE INCREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-24-2020 increased close price > 10% from $0.04 to $0.05

Jul. 23, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-23-2020 decreased close price > 10% from $0.05 to $0.04

Jul. 22, 2020CLOSE PRICE INCREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-22-2020 increased close price > 10% from $0.04 to $0.05

Jul. 21, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-21-2020 decreased close price > 10% from $0.05 to $0.04

Jul. 15, 2020CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPXD) on 07-15-2020 decreased close price > 10% from $0.05 to $0.04

More Rebus Holdings Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 14, 2024APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 12-14-2024 decreased stock price > 10% from $0.22 to $0.16

Dec. 14, 2024QTTB STOCK PRICE DECREASE: Q32 Bio Inc on 12-14-2024 decreased stock price > 10% from $4.25 to $3.70

Dec. 14, 2024APVO STOCK PRICE DECREASE: Com Par $0.001/Aptevo Therapeutics Inc on 12-14-2024 decreased stock price > 10% from $5.63 to $4.09

Dec. 14, 2024CHRO STOCK PRICE DECREASE: Chromocell Therapeutics Corp on 12-14-2024 decreased stock price > 10% from $0.69 to $0.59

Dec. 14, 2024DTIL STOCK PRICE DECREASE: Precision Biosciences Inc on 12-14-2024 decreased stock price > 10% from $6.12 to $5.44

Dec. 14, 2024MGX STOCK PRICE DECREASE: Metagenomi Inc on 12-14-2024 decreased stock price > 10% from $3.86 to $3.24

Dec. 14, 2024INO STOCK PRICE DECREASE: Com Par $0.001/Inovio Pharmaceuticals Inc. on 12-14-2024 decreased stock price > 10% from $3.76 to $2.32

Dec. 14, 2024ONCO STOCK PRICE DECREASE: Onconetix Inc on 12-14-2024 decreased stock price > 10% from $0.47 to $0.40

Dec. 14, 2024TTOO STOCK PRICE DECREASE: Com Par $0.001/T2 Biosystems Inc on 12-14-2024 decreased stock price > 10% from $0.45 to $0.37

Dec. 14, 2024SHOTW STOCK PRICE DECREASE: Wt Exp/Safety Shot Inc on 12-14-2024 decreased stock price > 10% from $0.25 to $0.22

More Biotechnology Dividend News
X
Search Dividend Investor